MintLean R·
Aurobindo Pharma’s investors await next leg of growth
Growth would be aided by the Pen-G project ramp-up, Lannett’s integration, new US product launches, expansion in Europe and contribution from higher-margin businesses
Read at Mint →
Markets · 1 sources covering this
Aurobindo Pharma’s investors await next leg of growth
Growth would be aided by the Pen-G project ramp-up, Lannett’s integration, new US product launches, expansion in Europe and contribution from higher-margin businesses
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/a552e374e880bd094e2fa1243c291f36ed2f88de" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Aurobindo Pharma’s investors await next leg of growth"></iframe>
